Examples of Blue Chip Dividend Stocks
Blue chip stocks generally have high market caps and a good reputation. Here are some popular examples


Published May 21, 2024.

Blue chip stocks are considered financially stable and well-established companies that trade on the global financial markets. Some of the key characteristics of these organizations include significant market capitalization and being leaders in their industries. Generally speaking, blue chip stocks are considered safer than small companies.
Blue chip stocks are attractive for their lucrative and safer appeal that comes from established companies. From capital appreciation to dividend status to reliable histories, there is a long list of potential advantages.
However, you should never consider anything in the trading world as guaranteed. All instruments and strategies come with a certain risk that could result in potential losses just as easily as potential profit.
» New to stocks? Be sure to check out our stock trading for beginners article
5 Examples of Blue Chip Stocks and Their Market Capitalization
- Apple Inc (AAPL) - $2.629 trillion
- Johnson & Johnson (JNJ) - $350.60 billion
- Procter & Gamble Co. (PG) - $346.83 billion
- Coca-Cola Co. (KO) - $238.82 billion
- Microsoft (MSFT) - $2.45 trillion
Note: Fortrade offers the ability to trade the price changes of stocks with CFDs and NOT to buy/sell ownership of stocks itself.
» Learn more about trading platforms with Fortrade
1. Apple (AAPL)
Apple, a tech giant in consumer electronics, digital services, and software, has been exceptionally reliable in the 21st century. After discontinuing dividends in 2012, they've consistently delivered strong quarterly payouts.
Still, the downturn in 2022 in the tech sector proved that even the tech titan could go through a rough patch, mainly from tighter monetary policy, weaker global economic conditions, and supply chain chaos.
» Need help understanding economic factors? Learn to use an economic calendar
2. Johnson & Johnson (JNJ)
Johnson & Johnson is one of the world's largest, most diversified multinational healthcare corporations, maintaining a juggernaut presence in various fields, such as consumer healthcare products, medical devices, and pharmaceuticals. The conglomerate has enjoyed a long history of financial prosperity, routinely posting strong revenues in any market. Moreover, Johnson & Johnson is well known for its exceptional dividend history.
While there are various risks that the company faces, such as regulatory challenges, litigation, and intellectual property, the business has weathered a wide array of storms.